Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
0.8100
0.00 (0.00%)
At close: Apr 29, 2025, 4:00 PM
0.8000
-0.0100 (-1.23%)
Pre-market: Apr 30, 2025, 8:43 AM EDT
CNTB Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 78.23 | 105.66 | 79.01 | 267.72 | 154.72 | Upgrade
|
| Short-Term Investments | 15.48 | 12.64 | 73.46 | - | 0.59 | Upgrade
|
| Trading Asset Securities | - | - | - | - | 2 | Upgrade
|
| Cash & Short-Term Investments | 93.71 | 118.3 | 152.47 | 267.72 | 157.31 | Upgrade
|
| Cash Growth | -20.79% | -22.41% | -43.05% | 70.18% | 218.37% | Upgrade
|
| Accounts Receivable | 0.79 | - | - | - | - | Upgrade
|
| Other Receivables | 0.26 | 0.35 | - | 7.41 | - | Upgrade
|
| Receivables | 1.05 | 0.35 | - | 7.41 | - | Upgrade
|
| Prepaid Expenses | 2.15 | 3.85 | 3.31 | - | 4.56 | Upgrade
|
| Other Current Assets | 0.05 | 0.05 | - | - | - | Upgrade
|
| Total Current Assets | 96.96 | 122.55 | 155.78 | 275.13 | 161.87 | Upgrade
|
| Property, Plant & Equipment | 4.24 | 4.74 | 8.47 | 12.89 | 1.21 | Upgrade
|
| Long-Term Investments | - | - | 9.44 | - | - | Upgrade
|
| Other Intangible Assets | 0.05 | 0.06 | 0.07 | 0.09 | 0.05 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.02 | 0.25 | 2.95 | 3.04 | Upgrade
|
| Total Assets | 101.28 | 127.38 | 174.01 | 291.05 | 166.17 | Upgrade
|
| Accounts Payable | 0.34 | 2.21 | 11.94 | 12.74 | 3.77 | Upgrade
|
| Accrued Expenses | 7.55 | 9.4 | 2.96 | - | 1.87 | Upgrade
|
| Current Portion of Leases | 0.15 | 0.29 | 0.19 | 0.1 | 0.09 | Upgrade
|
| Current Unearned Revenue | 0.16 | 13.32 | - | - | - | Upgrade
|
| Other Current Liabilities | 0.25 | 0.08 | 0.54 | 5.15 | 0.08 | Upgrade
|
| Total Current Liabilities | 8.46 | 25.29 | 15.62 | 17.99 | 5.82 | Upgrade
|
| Long-Term Debt | - | - | - | - | 317.3 | Upgrade
|
| Long-Term Leases | 0.02 | 0.18 | 0.25 | 0.03 | 0.05 | Upgrade
|
| Long-Term Unearned Revenue | - | - | 0.65 | 0.78 | - | Upgrade
|
| Other Long-Term Liabilities | 0.63 | 0.41 | - | - | - | Upgrade
|
| Total Liabilities | 9.12 | 25.88 | 16.52 | 18.8 | 323.16 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 439.36 | 432.4 | 628.66 | 628.64 | 6.35 | Upgrade
|
| Retained Earnings | -345.36 | -329.73 | -479.84 | -361.75 | -164.1 | Upgrade
|
| Treasury Stock | -0.18 | -0.18 | -0.18 | -0.18 | -0 | Upgrade
|
| Comprehensive Income & Other | -1.67 | -1.01 | 8.85 | 5.54 | 0.75 | Upgrade
|
| Shareholders' Equity | 92.17 | 101.5 | 157.49 | 272.26 | -156.99 | Upgrade
|
| Total Liabilities & Equity | 101.28 | 127.38 | 174.01 | 291.05 | 166.17 | Upgrade
|
| Total Debt | 0.18 | 0.47 | 0.43 | 0.13 | 317.44 | Upgrade
|
| Net Cash (Debt) | 93.53 | 117.84 | 152.04 | 267.59 | -160.13 | Upgrade
|
| Net Cash Growth | -20.63% | -22.49% | -43.18% | - | - | Upgrade
|
| Net Cash Per Share | 1.69 | 2.14 | 2.76 | 5.13 | -9.37 | Upgrade
|
| Filing Date Shares Outstanding | 55.35 | 55.1 | 55.04 | 55.08 | 17.09 | Upgrade
|
| Total Common Shares Outstanding | 55.35 | 55.1 | 55.04 | 55.08 | 17.09 | Upgrade
|
| Working Capital | 88.5 | 97.26 | 140.16 | 257.14 | 156.05 | Upgrade
|
| Book Value Per Share | 1.67 | 1.84 | 2.86 | 4.94 | -9.19 | Upgrade
|
| Tangible Book Value | 92.11 | 101.44 | 157.42 | 272.17 | -157.05 | Upgrade
|
| Tangible Book Value Per Share | 1.66 | 1.84 | 2.86 | 4.94 | -9.19 | Upgrade
|
| Machinery | 5.85 | 5.68 | 5.84 | 5.77 | 0.96 | Upgrade
|
| Construction In Progress | - | - | - | 3.7 | 0.29 | Upgrade
|
| Leasehold Improvements | 0.83 | 0.63 | 0.76 | 0.73 | 0.22 | Upgrade
|
Updated Sep 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.